Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-7 of 7
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
16-May-2017Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) ConsortiumRuscito, I; Castillo-Tong, DC; Vergote, I; Ignat, I; Stanske, M, et al
18-Feb-2018Dynamics of the intratumoral immune response during progression of high-grade serous ovarian cancerStanske, M; Wienert, S; Castillo-Tong, DC; Kreuzinger, C; Vergote, I, et al
23-Sep-2016Platinum-based chemotherapy induces methylation changes in blood DNA associated with overall survival in ovarian cancer patientsFlanagan, JM; Wilson, A; Koo, C; Masrour, N; Gallon, J, et al
9-Jan-2017Value of neoadjuvant chemotherapy for newly diagnosed advanced ovarian cancer: a European perspective.Fotopoulou, C; Sehouli, J; Aletti, G; Harter, P; Mahner, S, et al
28-Mar-2017Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multi-centre studyPhelps, DL; Borley, J; Flower, K; Dina, R; Darb-Esfahani, S, et al
2-Oct-2017A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer.Kreuzinger, C; Geroldinger, A; Smeets, D; Braicu, EI; Sehouli, J, et al
1-Aug-2018Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study)Ruscito, I; Castillo-Tong, DC; Vergote, I; Ignat, I; Stanske, M, et al